Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 4
2018 6
2019 5
2020 10
2021 8
2022 7
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Avelumab in gastric cancer.
Roviello G, D'Angelo A, Generali D, Pittacolo M, Ganzinelli M, Iezzi G, Manzini N, Sobhani N. Roviello G, et al. Among authors: sobhani n. Immunotherapy. 2019 Jun;11(9):759-768. doi: 10.2217/imt-2019-0011. Epub 2019 May 6. Immunotherapy. 2019. PMID: 31060469 Review.
Advances in anti-BRAF therapies for lung cancer.
Roviello G, D'Angelo A, Sirico M, Pittacolo M, Conter FU, Sobhani N. Roviello G, et al. Among authors: sobhani n. Invest New Drugs. 2021 Jun;39(3):879-890. doi: 10.1007/s10637-021-01068-8. Epub 2021 Jan 21. Invest New Drugs. 2021. PMID: 33474634 Free PMC article. Review.
MR1-Restricted T Cells in Cancer Immunotherapy.
Flores-Villanueva P, Sobhani N, Wang X, Li Y. Flores-Villanueva P, et al. Among authors: sobhani n. Cancers (Basel). 2020 Aug 3;12(8):2145. doi: 10.3390/cancers12082145. Cancers (Basel). 2020. PMID: 32756356 Free PMC article. Review.
Bevacizumab in small cell lung cancer.
Roviello G, Sobhani N, Generali D. Roviello G, et al. Among authors: sobhani n. Ann Transl Med. 2017 Sep;5(17):361. doi: 10.21037/atm.2017.06.44. Ann Transl Med. 2017. PMID: 28936455 Free PMC article. No abstract available.
Cancer management during the COVID-19 world pandemic.
Sobhani N, Mondani G, Roviello G, Catalano M, Sirico M, D'Angelo A, Scaggiante B, Generali D. Sobhani N, et al. Cancer Immunol Immunother. 2023 Nov;72(11):3427-3444. doi: 10.1007/s00262-023-03524-1. Epub 2023 Aug 29. Cancer Immunol Immunother. 2023. PMID: 37642709 Review.
Lenvatinib for the treatment of renal cell carcinoma.
Roviello G, Corona SP, Bozza G, Aieta M, Generali D, Rodriquenz MG, Mileo AM, Imperatori M, Ianza A, Conca R, Sobhani N. Roviello G, et al. Among authors: sobhani n. Expert Opin Investig Drugs. 2018 May;27(5):507-512. doi: 10.1080/13543784.2018.1472235. Epub 2018 May 14. Expert Opin Investig Drugs. 2018. PMID: 29718721 Free article. Review.
Cancer/testis antigens: from serology to mRNA cancer vaccine.
Fan C, Qu H, Wang X, Sobhani N, Wang L, Liu S, Xiong W, Zeng Z, Li Y. Fan C, et al. Among authors: sobhani n. Semin Cancer Biol. 2021 Nov;76:218-231. doi: 10.1016/j.semcancer.2021.04.016. Epub 2021 Apr 25. Semin Cancer Biol. 2021. PMID: 33910064 Review.
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy.
Sobhani N, Tardiel-Cyril DR, Davtyan A, Generali D, Roudi R, Li Y. Sobhani N, et al. Cancers (Basel). 2021 Mar 22;13(6):1440. doi: 10.3390/cancers13061440. Cancers (Basel). 2021. PMID: 33809974 Free PMC article. Review.
49 results